MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/04/6601-85-96$20.00
Mol Pharmacol 66:85-96, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moretti, M.
Right arrow Articles by Gotti, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moretti, M.
Right arrow Articles by Gotti, C.

Nicotinic Acetylcholine Receptor Subtypes Expression during Rat Retina Development and Their Regulation by Visual Experience

Milena Moretti, Silvia Vailati, Michele Zoli, Giordano Lippi, Loredana Riganti, Renato Longhi, Alessandro Viegi, Francesco Clementi, and Cecilia Gotti

CNR, Institute of Neuroscience, Cellular and Molecular Pharmacology, Department of Medical Pharmacology, and Center of Excellence on Neurodegenerative Diseases, University of Milan, Milan, Italy (M.M., S.V., L.R., F.C., C.G.); Department of Biomedical Sciences, Section of Physiology, University of Modena and Reggio Emilia, Modena, Italy (M.Z., G.L.); Consiglio Nazionale delle Ricerche, Institute of Chemistry of Molecular Recognition, Milan, Italy (R.L.); and Scuola Normale Superiore, Pisa, Italy (A.V.)

By acting through retinal nicotinic acetylcholine receptors (nAChRs), acetylcholine plays an important role in the development of both the retina and central visual pathways. Ligand binding and immunoprecipitation studies with subunit-specific antibodies showed that the expression of {alpha}Bungarotoxin ({alpha}Bgtx) and high-affinity epibatidine (Epi) receptors is regulated developmentally and increases until postnatal day 21 (P21). The increase in Epi receptors is caused by a selective increase in the subtypes containing the {alpha}2, {alpha}4, {alpha}6, {beta}2, and {beta}3 subunits. Immunopurification studies revealed three major populations of Epi receptors on P21: {alpha}6* receptors (26%), which contain the {alpha}6{beta}3{beta}2, {alpha}6{alpha}4{beta}3{beta}2, and {alpha}6{alpha}3/{alpha}2{beta}3{beta}2 subtypes; {alpha}4(non-{alpha}6)* receptors (60%), which contain the {alpha}2{alpha}4{beta}2 and {alpha}4{beta}2 subtypes; and (non-{alpha}4/non-{alpha}6)* receptors (14%), which contain the {alpha}2{beta}2/{beta}4 and {alpha}3{beta}2/{beta}4 subtypes. These three populations can be pharmacologically discriminated using {alpha}conotoxin MII, which binds the {alpha}6* population with high affinity. In situ hybridization showed that the transcripts for all of the subunits are heterogeneously distributed throughout retinal neurons at P21, with {alpha}3, {alpha}6, and {beta}3 transcripts preferentially concentrated in the ganglion cell layer, {alpha}5 in the inner nuclear layer, and {alpha}4 and {beta}2 distributed rather homogeneously. To investigate whether nAChR expression is affected by visual experience, we also studied dark-reared P21 rats. Visual deprivation had no effect on the expression of {alpha}Bgtx receptors or the developmentally regulated Epi receptors containing the {alpha}2, {alpha}6, and/or {beta}3 subunits but significantly increased the expression of the Epi receptors containing the {alpha}4 and {beta}2 subunits. Overall, this study demonstrates that the retina is the rat neural region that expresses the widest array of nAChR subtypes. These receptors have a specific distribution, and their expression is finely regulated during development and by visual experience.


Received October 29, 2003; accepted March 19, 2004

Address correspondence to: Dr. Cecilia Gotti, CNR, Institute of Neuroscience, Section of Cellular and Molecular Pharmacology, Department of Medical Pharmacology, University of Milan, Via Vanvitelli 32, 20129 Milano, Italy. E-mail: c.gotti{at}in.cnr.it




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
C. Gotti, M. Moretti, N. M. Meinerz, F. Clementi, A. Gaimarri, A. C. Collins, and M. J. Marks
Partial Deletion of the Nicotinic Cholinergic Receptor {alpha}4 or {beta}2 Subunit Genes Changes the Acetylcholine Sensitivity of Receptor-Mediated 86Rb+ Efflux in Cortex and Thalamus and Alters Relative Expression of {alpha}4 and {beta}2 Subunits
Mol. Pharmacol., June 1, 2008; 73(6): 1796 - 1807.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M.-H. Chan, Y.-C. Tang, T.-H. Chien, and H.-H. Chen
Toluene Exposure during the Brain Growth Spurt Reduced Behavioral Responses to Nicotine in Young Adult Rats: A Potential Role for Nicotinic Acetylcholine Receptors in Fetal Solvent Syndrome
Toxicol. Sci., February 1, 2008; 101(2): 286 - 293.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Kabbani, M. P. Woll, R. Levenson, J. M. Lindstrom, and J.-P. Changeux
Intracellular complexes of the 2 subunit of the nicotinic acetylcholine receptor in brain identified by proteomics
PNAS, December 18, 2007; 104(51): 20570 - 20575.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
N. A. Dmitrieva, C. E. Strang, and K. T. Keyser
Expression of Alpha 7 Nicotinic Acetylcholine Receptors by Bipolar, Amacrine, and Ganglion Cells of the Rabbit Retina
J. Histochem. Cytochem., May 1, 2007; 55(5): 461 - 476.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
X. Xu, M. M. Scott, and E. S. Deneris
Shared Long-Range Regulatory Elements Coordinate Expression of a Gene Cluster Encoding Nicotinic Receptor Heteromeric Subtypes
Mol. Cell. Biol., August 1, 2006; 26(15): 5636 - 5649.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Quik and J. M. McIntosh
Striatal {alpha}6* Nicotinic Acetylcholine Receptors: Potential Targets for Parkinson's Disease Therapy
J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 481 - 489.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. J. Groot-Kormelink, S. Broadbent, M. Beato, and L. G. Sivilotti
Constraining the Expression of Nicotinic Acetylcholine Receptors by Using Pentameric Constructs
Mol. Pharmacol., February 1, 2006; 69(2): 558 - 563.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. M. Marritt, B. C. Cox, R. P. Yasuda, J. M. McIntosh, Y. Xiao, B. B. Wolfe, and K. J. Kellar
Nicotinic Cholinergic Receptors in the Rat Retina: Simple and Mixed Heteromeric Subtypes
Mol. Pharmacol., December 1, 2005; 68(6): 1656 - 1668.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. R. Turner and K. J. Kellar
Nicotinic Cholinergic Receptors in the Rat Cerebellum: Multiple Heteromeric Subtypes
J. Neurosci., October 5, 2005; 25(40): 9258 - 9265.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Gotti, M. Moretti, A. Zanardi, A. Gaimarri, N. Champtiaux, J.-P. Changeux, P. Whiteaker, M. J. Marks, F. Clementi, and M. Zoli
Heterogeneity and Selective Targeting of Neuronal Nicotinic Acetylcholine Receptor (nAChR) Subtypes Expressed on Retinal Afferents of the Superior Colliculus and Lateral Geniculate Nucleus: Identification of a New Native nAChR Subtype {alpha}3{beta}2({alpha}5 or {beta}3) Enriched in Retinocollicular Afferents
Mol. Pharmacol., October 1, 2005; 68(4): 1162 - 1171.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
X.-Q. Ren, S.-B. Cheng, M. W. Treuil, J. Mukherjee, J. Rao, K. H. Braunewell, J. M. Lindstrom, and R. Anand
Structural Determinants of {alpha}4{beta}2 Nicotinic Acetylcholine Receptor Trafficking
J. Neurosci., July 13, 2005; 25(28): 6676 - 6686.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Gotti, M. Moretti, F. Clementi, L. Riganti, J. M. McIntosh, A. C. Collins, M. J. Marks, and P. Whiteaker
Expression of Nigrostriatal {alpha}6-Containing Nicotinic Acetylcholine Receptors Is Selectively Reduced, but Not Eliminated, by {beta}3 Subunit Gene Deletion
Mol. Pharmacol., June 1, 2005; 67(6): 2007 - 2015.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Quik, S. Vailati, T. Bordia, J. M. Kulak, H. Fan, J. M. McIntosh, F. Clementi, and C. Gotti
Subunit Composition of Nicotinic Receptors in Monkey Striatum: Effect of Treatments with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine or L-DOPA
Mol. Pharmacol., January 1, 2005; 67(1): 32 - 41.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics